Effects of Vitamin D Supplementation on Antimycobacterial Immunity
NCT ID: NCT00157066
Last Updated: 2007-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
230 participants
INTERVENTIONAL
2002-12-31
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Adjunctive Vitamin D in Tuberculosis Treatment
NCT00419068
Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment
NCT00918086
A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients
NCT00366470
Role of Vitamin D in Innate Immunity to Tuberculosis
NCT01244204
Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia
NCT01657656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ergocalciferol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tuberculosis (TB) contact or TB patient
Exclusion Criteria
* Breastfeeding
* Hyperparathyroidism
* Sarcoidosis
* Renal failure
* HIV infection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
University of Cape Town
OTHER
Newham Chest Clinic, London E7 8QP, UK
UNKNOWN
Northwick Park Hospital, Harrow, UK
OTHER
Department of Clinical Biochemistry, Homerton Hospital, London E9 6SR, UK
OTHER
Environmental Health Department, London Borough of Newham, London E15 4SF, UK
UNKNOWN
Wellcome Trust
OTHER
Barts & The London NHS Trust
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adrian R Martineau, B Med Sci, MBBS, DTM&H, MRCP
Role: PRINCIPAL_INVESTIGATOR
Centre for Health Sciences, Barts and The London, QMUL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuberculosis Clinic, Newham Chest Clinic
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, Rainbow SJ, Berry JL, Griffiths CJ. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007 Jul 15;176(2):208-13. doi: 10.1164/rccm.200701-007OC. Epub 2007 Apr 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AM1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.